12/11
09:27 pm
sgry
How the Narrative Surrounding Surgery Partners Is Shifting Amid Near Term Headwinds and Long Term Hopes [Yahoo! Finance]
Medium
Report
How the Narrative Surrounding Surgery Partners Is Shifting Amid Near Term Headwinds and Long Term Hopes [Yahoo! Finance]
12/11
06:25 pm
sgry
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
Medium
Report
Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering
12/11
10:00 am
sgry
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Low
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
12/11
09:13 am
sgry
Surgery Partners, Inc. Announces Add-On Senior Notes Offering [Yahoo! Finance]
Medium
Report
Surgery Partners, Inc. Announces Add-On Senior Notes Offering [Yahoo! Finance]
12/11
08:23 am
sgry
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
Low
Report
Surgery Partners, Inc. Announces Add-On Senior Notes Offering
12/8
12:00 pm
sgry
Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care
Low
Report
Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care
11/25
01:57 pm
sgry
Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/25
05:21 am
sgry
Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound [Yahoo! Finance]
Low
Report
Assessing Surgery Partners (SGRY) Valuation Following Fed-Driven Investor Optimism and Recent Share Price Rebound [Yahoo! Finance]
11/24
10:40 am
sgry
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at JPMorgan Chase & Co. from $27.00 to $20.00. They now have a "neutral" rating on the stock.
Low
Report
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at JPMorgan Chase & Co. from $27.00 to $20.00. They now have a "neutral" rating on the stock.
11/21
07:08 am
sgry
Surgery Partners (NASDAQ:SGRY) was given a new $18.00 price target on by analysts at Barclays PLC.
Low
Report
Surgery Partners (NASDAQ:SGRY) was given a new $18.00 price target on by analysts at Barclays PLC.
11/20
10:00 am
sgry
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
Medium
Report
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Surgery Partners, Inc. - SGRY
11/19
05:18 am
sgry
3 Reasons to Sell SGRY and 1 Stock to Buy Instead [Yahoo! Finance]
Medium
Report
3 Reasons to Sell SGRY and 1 Stock to Buy Instead [Yahoo! Finance]
11/18
01:21 pm
sgry
Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Surgery Partners (NASDAQ:SGRY) had its "sell (e+)" rating reaffirmed by analysts at
Weiss Ratings.
11/17
12:58 pm
sgry
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Mizuho from $28.00 to $22.00. They now have an "outperform" rating on the stock.
Low
Report
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Mizuho from $28.00 to $22.00. They now have an "outperform" rating on the stock.
11/13
10:48 am
sgry
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at UBS Group AG from $34.00 to $29.00. They now have a "buy" rating on the stock.
Medium
Report
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at UBS Group AG from $34.00 to $29.00. They now have a "buy" rating on the stock.
11/12
04:23 am
sgry
1 Small-Cap Stock for Long-Term Investors and 2 We Avoid [Yahoo! Finance]
Low
Report
1 Small-Cap Stock for Long-Term Investors and 2 We Avoid [Yahoo! Finance]
11/11
04:37 pm
sgry
Why Surgery Partners (SGRY) Is Down 26.1% After Lower Q3 Results and Reduced 2025 Revenue Guidance [Yahoo! Finance]
Low
Report
Why Surgery Partners (SGRY) Is Down 26.1% After Lower Q3 Results and Reduced 2025 Revenue Guidance [Yahoo! Finance]
11/11
10:31 am
sgry
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Royal Bank Of Canada from $35.00 to $31.00. They now have an "outperform" rating on the stock.
Medium
Report
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Royal Bank Of Canada from $35.00 to $31.00. They now have an "outperform" rating on the stock.
11/11
09:08 am
sgry
SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures [Yahoo! Finance]
Medium
Report
SGRY Q3 Deep Dive: Guidance Cut Highlights Volume and M&A Timing Pressures [Yahoo! Finance]
11/11
08:43 am
sgry
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Benchmark Co. from $35.00 to $30.00. They now have a "buy" rating on the stock.
Low
Report
Surgery Partners (NASDAQ:SGRY) had its price target lowered by analysts at Benchmark Co. from $35.00 to $30.00. They now have a "buy" rating on the stock.
11/10
04:22 pm
sgry
Surgery Partners Inc (SGRY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... [Yahoo! Finance]
Low
Report
Surgery Partners Inc (SGRY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amidst ... [Yahoo! Finance]
11/10
01:51 pm
sgry
Why Surgery Partners (SGRY) Stock Is Trading Lower Today [Yahoo! Finance]
Low
Report
Why Surgery Partners (SGRY) Stock Is Trading Lower Today [Yahoo! Finance]
11/10
01:33 pm
sgry
Surgery Partners, Inc. (SGRY) Q3 2025 Earnings Call Transcript [Seeking Alpha]
Medium
Report
Surgery Partners, Inc. (SGRY) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/10
08:18 am
sgry
Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5% [Yahoo! Finance]
High
Report
Surgery Partners (NASDAQ:SGRY) Posts Q3 Sales In Line With Estimates But Stock Drops 13.5% [Yahoo! Finance]
11/10
07:59 am
sgry
Surgery Partners, Inc. Announces Third Quarter 2025 Results [Yahoo! Finance]
High
Report
Surgery Partners, Inc. Announces Third Quarter 2025 Results [Yahoo! Finance]